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Summary Type 11 pneumocytes and Clara cells, both epithelial cells that possess an active uptake system for
polyamines, have been identified as possible precursor cells of at least some types of lung tumours. In this
study we have investigated whether human pulmonary tumours exhibit putrescine uptake. Lung slices from
both tumoral tissue and non-tumoral tissue, obtained from patients undergoing surgery for lung cancer, were
incubated with radiolabelled putrescine at both 37C and 4'C. The accumulation of putrescine was evaluated
by its apparent kinetic parameters, in the presence or absence of cystamine, and by autoradiography. The
investigated tumoral tissue (six squamous carcinomas and five adenocarcinomas) did not show accumulation
of putrescine above that attributable to simple diffusion, except for one adenocarcinoma. In this specimen
autoradiography showed that the accumulation was not specifically associated with any particular cell type,
but that practically every cell accumulated putrescine. We conclude that human pulmonary tumours do not
accumulate polyamines in a manner similar to normal pulmonary epithelial cells.
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Much more than any other major organ examined, normal
lung tissue appears to accumulate polyamines via an active
uptake system obeying Michaelis-Menten kinetics (Smith et
al., 1982). The propensity of normal lung tissue to
accumulate polyamines was discovered after it had been
found that the highly selective pneumotoxic herbicide para-
quat is actively accumulated in lung tissue (Rose et al., 1974;
Lock et al., 1976) and that this accumulation occurs because
paraquat is 'mistaken' for the structurally somewhat similar
polyamines (Smith, 1985). The site of this uptake has been
convincingly demonstrated to be essentially made up by the
alveolar epithelium, i.e. type I and type II pneumocytes, as
shown by autoradiography in both animal and human lungs
(Nemery et al., 1987; Wyatt et al., 1988; Dinsdale et al.,
1991; Hoet et al., 1993). In addition, the non-ciliated bron-
chiolar (Clara) cells of the rat are also a site of uptake, at
least in vitro (Nemery et al., 1987; Wyatt et al., 1988), but
this could neither be confirmed or denied for the human lung
(Hoet et al., 1993). Neither the alveolar cells nor the Clara
cells are characterised by a high proliferation rate in the
normal lung (Kauffman, 1980), and thus the reasons for the
substantial accumulation of polyamines by lung tissue are
still unclear.
Given that a high polyamine uptake appears to be a
specific feature of lung epithelial cells, it was logical to
investigate whether some pulmonary epithelium-derived
tumours would also exhibit a high polyamine uptake,
irrespective of their proliferation rate.
Despite intensive study, the histogenetic origin of pul-
monary tumours is still vague for most of the tumour types.
On the basis of findings obtained in mice (Thaete and Mal-
kinson, 1990; Malkinson, 1991) and in dog (Ten Have-
Opbroek et al., 1990), adenocarcinomas have been considered
to derive from type II pneumocytes. The origin of squamous
cell carcinomas is still unclear, but there are suggestions that
both Clara cells and type II pneumocytes could be implicated
in human pulmonary epithelial tumours (Boyd and Reznik-
Schiiller, 1984; Devereux et al., 1986). Thus, if some tumours
derive from Clara cells or type II pneumocytes, it is con-
ceivable that these tumours also take up putrescine actively,
in a way similar to the normal Clara cells or type II
pneumocytes.
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In this study, human lung tumours have been incubated in
the presence of radiolabelled putrescine, and we have com-
pared the uptake of putrescine in the neoplastic tissue with
that in the surrounding parenchyma.
Materials and methods
Reagents
[1,4-'4C]Putrescine dihydrochloride (110 mCi mmol-') and
[1,4n-3H]putrescine dihydrochloride (24 mCi mmol-') were
purchased from Amersham International (Brussels, Belgium).
Soluene 350 tissue solubiliser, Emulsifier Safe and Ultima
Gold scintillants as well as plastic scintillation vials (20ml
and 5 ml) were purchased from Packard (Zellik, Belgium).
Ilford Nuclear Research Emulsion Gel K2 and Ilford
Phenisol were purchased from Ilford Photo (Brussels, Bel-
gium). Putrescine dihydrochloride, glutaraldehyde and glu-
cose were purchased from Sigma Germany (Filterservice,
Eupen, Belgium). All other chemicals were obtained from
U.C.B. Belgium (Vel, Leuven, Belgium).
Preparation and incubation oflung slices
Both normal and tumoral lung tissue samples were obtained
from 11 patients (one female, aged 64 years; ten males, aged
57-77 years) undergoing lobectomy or pneumonectomy for
lung cancer (Table I). (Data from the normal tissue of ten of
these subjects are included in a previously published article;
Hoet et al., 1993). Approval for using this type of tissue was
obtained from the Ethical Committee of the Faculty of
Medicine. Within minutes after resection, large portions of
normal and tumoral tissue were dissected from the surgical
specimen. The tissue pieces were placed in separate beakers
in Krebs Ringer phosphate buffer (KRPB), containing
sodium chloride (130 mM), potassium chloride (5.4 mM), cal-
cium chloride (1.9 mM), magnesium sulphate (1.29 mM),
disodium hydrogen phosphate (10 mM), glucose (11 mM)
(pH 7.4) at room temperature.
Within 1 h, 0.7 mm-thick slices were prepared from both
normal and tumoral tissues with a Mcllwain tissue chopper
(Mickle Laboratories, Surrey, UK). The slices, with cut sur-
faces of about 0.5 cm2, were weighed and incubated in bat-
ches of approximately 30 mg in 3 ml of KRPB in 40 ml
polyethylene flasks placed in a shaking water bath (120-140Putrescine accumulation in human pulmonary tumours
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Table I Characteristics of patients ranked by sex and age
Age
Patient no. Sex (years) Final diagnosis Parenchymaa
19 F 64 Adenocarcinoma Normal
15 M 57 Squamous carcinoma Normal
17 M 63 Squamous carcinoma Normal
29 M 63 Adenocarcinoma Normal
20 M 64 Squamous carcinoma Emphysema
16 M 64 Adenocarcinoma Normal
22 M 65 Squamous carcinoma Normal
13 M 66 Squamous carcinoma Normal
18 M 67 Squamous carcinoma Normal
25 M 69 Adenocarcinoma Normal
28 M 77 Adenocarcinoma Normal
aHistological appearance of peritumoral parenchyma. F, female; M, male.
strokes min-') at 37C (or at 4°C) (O'Neil et al., 1977). The
slices were incubated in KRPB containing putrescine
(2.5-80jLM) and [1,4-'4C]putrescine (0.1 Ci per incubation
flask) in the presence or absence of 50gM cystamine. Putres-
cine uptake was determined as described previously (Hoet et
al., 1993), by measuring tissue-associated radioactivity.
The tissue-medium ratio of radioactivity was calculated
as: (tissue radioactivity/0.7)/(medium radioactivity post inc-
ubation), with the factor 0.7 representing the 70% aqueous
portion of the tissue containing free putrescine.
Autoradiography
Lung slices were incubated for 30 min at 37C in KRPB
containing 2.5 JM putrescine and [1,4n-3H]putrescine (500
ILCitLmol
-').
At the end of the incubation, the slices were fixed in 6.5%
glutaraldehyde in 0.1% cacodylate buffer (pH 7.4) and
prepared for autoradiography, as previously described by
Nemery et al. (1987) and Dinsdale et al. (1991). Slices for
light microscopy were embedded in EPON 812 resin and
sections of 1 tLm thickness were mounted onto microscope
slides. The slides were dipped at 40°C into an Ilford K2
nuclear emulsion (25%), dried, and kept at 4°C in the dark.
After 50 days, the slides were developed (Ilford Phenisol,
15 min), fixed (1% acetic acid 2 min, 30% sodium thiosul-
phate) and stained (0.1% toluidine blue in 0.1% borax, 37TC,
9 min).
Analysis ofdata
When intra-individual duplicate or triplicate determinations
were available, an average value was taken. The apparent
accumulation obtained at 37C was considered to represent
the sum of the active uptake and the passive uptake by
diffusion, with the latter being estimated from the incuba-
tions at 4°C. All weights are wet weights.
The maximum rate of uptake, Vmax (expressed in nmol g-
h-'), is achieved at infinite substrate concentration, and Km
(expressed in jiM substrate) is the medium concentration at
which the rate of uptake is half Vmax. The apparent kinetic
parameters were calculated from a Hanes-Woolf plot
(Engel, 1981).
Data from control and treated slices were compared by
Student's t-test for paired data, or by analysis of variance
with Duncan grouping, using the SAS/STAT package (6th
version). The level of significance was set at P< 0.05.
Results
Putrescine accumulation
The macroscopically normal tissue accumulated putrescine,
in an active manner, as described previously (Hoet et al.,
1993) (Figure 1). In the present group of subjects, this uptake
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Figure 1 Accumulation of ['4C]putrescine in normal and tumoral
tissue. Slices from human lung prepared from normal paren-
chyma and from the tumour were incubated for 30 min at 37°C
or 4°C, in medium containing various concentrations of
['4C]putrescine (2.5-80pM). Values obtained for the accumula-
tion of putrescine in normal lung slices at 4°C (not shown) were
not subtracted from those obtained at 37°C (0). The values for
tumour lung slices were split between adenocarcinomas (n = 5)
(A) and squamous carcinomas (n = 6) (V), the values obtained
at 4°C (U) were not subtracted.
was characterised by a mean Km of 9.9 jIM and a mean Vmax
of 297 nmol g-' h-'. No differences were found between
tissue from patients with adenocarcinoma (Km 10.21AM, Vmax
384 nmol g-' h-') or squamous carcinoma (Km 10.2 jIM, Vmax
218 nmol g-' h-').
In contrast, the accumulation of putrescine in tumoral
tissue was linear with the medium concentration, both at 4°C
and 37°C. When the data were grouped according to type of
neoplasm, no differences in the rate of putrescine accumula-
tion were found.
Figure 2 shows that, in the tumoral tissue, the tis-
sue-medium ratio of radioactivity was usually not higher
than 1, indicating that the measured tissue radioactivity was
essentially due to passive diffusion into the tissue. In one
sample (sample 16) a higher ratio was observed.
Co-incubation of normal parenchyma with putrescine in
the presence of 50jIM cystamine, a known competitive
inhibitor of putrescine uptake (Lewis et al., 1989), resulted,
as previously reported (Hoet et al., 1993), in reduced
accumulation of label (data not shown). In contrast, uptake
by tumoral tissue was not affected by cystamine, except in
samples from patient 16. In this sample the uptake was
reduced, as in non-tumoral tissue, but levels were still higher
than those attributable to passive diffusion.
Autoradiography
Autoradiography was consistent with the data obtained for
the accumulation of [1,4-'4C]putrescine: no labelling was
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Figure 2 Tissue-medium ratio radioactivity of human tumoral
and peritumoral lung tissue incubated with ['4C]putrescine. Slices
were incubated for 30 min at 37°C or 4°C, in a medium contain-
ing 10 JM (a) or 80 tM (b) ['4C]putrescine. The peritumoral tissue
of patient 25 was not incubated at 4°C. _, 4°C; 1EN, 37°C
tumour; FII, 37°C normal.
found in the tumoral tissue, except in sample 16 (Figure 3).
This peculiar tumoral sample showed labelling all over the
tissue section, with no concentration over any particular cell
type.
Discussion
The pulmonary tumours studied did not show evidence of
accumulation of putrescine, except in one case.
The cellular accumulation of a compound may be con-
sidered as occurring via an active process when the
accumulation: (i) occurs against a concentration gradient; (ii)
is energy dependent; (iii) obeys saturation kinetics; and (iv)
shows structure specificity. The pulmonary uptake of putres-
cine and other polyamines has been shown to fulfil these
criteria when normal lung tissue or pulmonary epithelial cells
from animals or humans were studied (Smith et al., 1982;
Nemery et al., 1987; Hoet et al., 1993; 1994). None of these
requirements appeared to be met in the present study in
which pulmonary tumoral tissue was examined:
(i) There was no evidence for accumulation of putrescine
against a concentration gradient in the neoplastic tissue
(Figure 2). Indeed the tissue-medium ratio of the
radioactivity after incubation with 10 or 80 LM putres-
cine was close to unity, whereas this ratio was always
higher in the surrounding normal tissue. In some of the
tumours the tissue-medium ratio was somewhat higher
than unity, indicating that some active uptake could
have taken place. An alternative explanation for this
phenomenon is that some putrescine became bound to
cellular components after entering the cell.
Figure 3 Autoradiographs of tumoral lung tissue of sample 16
incubated with 2.5JM [3H]putrescine for 30 min. Resin sections,
I lim thick, of tumoral lung tissue of sample 16 (see Table I),
stained with toluidine blue and examined by light microscopy. In
contrast to the other tumours where no labelling was found, in
sample 16 there is diffuse labelling over all the cells. Little or no
labelling is found in connective tissue. N, neoplasm; C, connec-
tive tissue; V, vena. Bars = 20pim.
(ii) The requirement of energy for a process to take place
can be verified by incubating the tissue at a low temper-
ature. Although the rate of accumulation was slightly
higher in lung tumour slices upon incubation at 37°C in
comparison to incubation at 4°C, in both instances the
accumulation was very low. The slightly greater uptake
at 37°C can be explained by the enhancement of passive
diffusion or by non-specific binding.
(iii) No evidence for saturation with increasing substrate
concentration was found in the tumoral tissue.
(iv) The absence of any inhibition of putrescine uptake in
tumoral tissue by cystamine, another substrate of the
pulmonary polyamine-uptake system (Lewis et al., 1989;
Hoet et al., 1993), provided further evidence for the lack
of a carrier-mediated uptake system for putrescine in the
tumoral tissue.
Our results thus indicate that there was no active uptake of
putrescine in the tumoral tissue investigated. There was one
possible exception: the tumoral tissue of patient 16 clearly
accumulated putrescine (although the levels were still lower
than in the surrounding normal parenchyma). This tumour
was a 4cm, large solid adenocarcinoma, with bronchiolar
epithelium included in between tumour nests, which did not
exhibit histopathological signs of high proliferative activity;
the peritumoural tissue appeared normal but compressed. On
the basis of the autoradiography, the accumulation in this
sample was as a result of accumulation in all the different
compartments of the tissue: the vascular tissue, the cells in
the connective tissue and the neoplastic cells. Because of the
general labelling, which was not seen in any other sample of
either healthy or tumoral tissue, one cannot conclude that the
tumour itself specifically accumulated putrescine. We have,
however, no explanation for the general non-specific
accumulation of putrescine in this tissue, except to hypo-
thesise that this was perhaps a particularly rapidly growing
tumour.
The polyamines (putrescine, spermidine, spermine) are ubi-
quitous amines that have been intensively studied in relation
to cellular growth and proliferation, more specifically in
relation to neoplastic growth and cell differentiation (Pegg,
1988). The polyamine content in cells is usually regulated by
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de novo synthesis and interconversion (Pegg et al., 1982).
However, some rapidly growing cells, both tumoral and non-
tumoral, require increased amounts of polyamines and,
therefore, possess a mechanism to accumulate polyamines
from the external milieu. Thus, it has been found that
polyamines and analogues are accumulated in erythrocytes of
mice bearing Lewis lung carcinoma but not in normal mice
(Moulinoux et al., 1991) and the rate of accumulation was
shown to be a good indicator for the proliferation of malig-
nant cells having a short doubling time (Moulinoux et al.,
1989a, b). Deprivation of polyamines has been shown to
inhibit tumour growth in mice (Sarhan et al., 1992) and the
uptake of putrescine has been shown to be cell-cycle depen-
dent in rat hepatocytes (Martin et al., 1991). The structure of
the polyamine uptake system has not been elucidated,
although a polyamine transport system has been recently
isolated from Escherichia coli (Furuchi et al., 1991;
Kashiwagi et al., 1991).
From an oncological point of view, the absence of a high
polyamine accumulation in the tumours studied here is per-
haps not surprising, since these solid tumours are not usually
considered to proliferate rapidly. However, we had antici-
pated that at least some tumours would still bear this charac-
teristic of their cells of origin, i.e. the alveolar or bronchiolar
epithelium. Type II pneumocytes and Clara cells are stem
cells of the lung epithelium (Breeze and Turk, 1984). These
dividing cells, or the precursors of these cells, are presumed
to undergo neoplastic conversion to give rise to adenocar-
cinomas or bronchioloalveolar carcinomas in mice (Thaete
and Malkinson, 1990). In a recent report, Ten Have-Opbroek
et al. (1994) suggested an oncofetal concept of bronchogenic
carcinoma development. They hypothesised that a local
retrodifferentiation of the bronchial epithelium, results in
undifferentiated primordial-like cells, which in turn give rise
to three possible tumour cell lines: alveolar (type II cell),
bronchial and primordial.
The histogenesis of tumours is often derived from
immunohistochemically staining of typical proteins or en-
zymes (Ten Have-Opbroek et al., 1990; Malkinson, 1991).
Our data, however, show that if human type II pneumocytes
or Clara cells are the stem cells of the more common pul-
monary epithelial tumours, they lose their ability or propen-
sity to accumulate polyamines during the neoplastic transfor-
mation. We did not have the opportunity to study bron-
chioloalveolar tumours, which only rarely undergo surgical
treatment. The same applies to small-cell lung tumours,
which, however, have a different cellular origin anyway.
Further characterisation of the polyamine uptake in
human pulmonary cancers, with e.g. coincubation with
polyamine synthesis inhibitors, such as a-difluoromethylor-
nithine (DFMO), which can strongly induce uptake (Janne et
al., 1981, 1991), were not performed because of the initial
negative results and the expected technical difficulties. Dur-
ing the present study it was found that slices from tumours
were more fragile than those from healthy human lung tissue;
these slices often broke into numerous fragments, which
hindered the recovery of the tissue after incubation. To com-
pensate for the incomplete recovery of the tumoral tissue, the
weight of the tissue was measured after the incubation. The
viability of the neoplastic tissue may be limited by the dense
cellular structure of the tumour which can possibly impair
the diffusion of nutrients. A possible alternative would be to
derive cell cultures from these tumours.
The absence of polyamine uptake in common lung cancers
has its repercussions for the treatment or diagnosis of these
conditions. The lack of an active polyamine uptake system
implies that anti-cancer drugs that enter the cell via the
polyamine uptake system, such as MGBG [methylglyxoxyl-
bis(guanyl-hydrazone)] (Williams-Ashman and Seidenfeld,
1986; Pegg, 1988; Janne et al., 1991) and Diam 3 (Khan et
al., 1991), will not be specifically transported into the tumour
cells. Another consequence of the lack of substantial
polyamine uptake in any of the examined lung neoplasms is
that the uptake of a polyamine-like molecule cannot be used
as a tool for the diagnosis or differential diagnosis of a
particular type of lung cancer.
In conclusion, we have shown that the examined neoplastic
lung tissue does not accumulate exogenous putrescine, in
contrast to the surrounding pulmonary tissue. The absence of
an active uptake system for polyamines was surprising,
especially for the adenocarcinomas, considering the fact that
their presumed progenitor cells, type II pneumocytes possess
an active polyamine-uptake system.
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